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Abstract Sphingosylphosphocholine (SPC), the N-deacylated
form of sphingomyelin (SM), is a naturally occurring lipid me-
diator. However, little is known about the metabolism of SPC.
We here report an in vitro assay system for SPC-phospholipase
C (PLC). Using this assay system, we demonstrated that
nSMase1 and nSMase2, human neutral sphingomyelinases
(SMases), are capable of hydrolyzing SPC e⁄ciently under
detergent-free conditions. Bacterial and plasmodial neutral
SMases also showed SPC-PLC activity. The substrate speci¢c-
ity of neutral SMases that hydrolyze SM, SPC, and monoradyl
glycerophosphocholine, but not diradyl glycerophosphocholine,
suggested that a hydrogen-bond donor at the C-2 or sn-2 posi-
tion in the substrate is required for recognition by the enzymes.
- 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Sphingosylphosphocholine (SPC), the N-deacylated form of
sphingomyelin (SM), exists in cells and blood plasma,
although its levels in normal tissues are very low [1^7].
When SPC is exogenously supplied to cells, it elicits various
responses including mitogenesis, focal contact assembly, mo-
bilization of Ca2þ, activation of a Kþ channel, and apoptosis,
depending on concentration and cell type [8]. Recently, SPC
has been shown to be a high-a⁄nity ligand for several types of
guanosine triphosphate (GTP)-binding protein-coupled recep-
tors [9^12]. Thus, SPC has been accepted as a naturally occur-
ring lipid mediator. However, very little is known about the
metabolism of SPC.
Sphingomyelinase (SMase) or SM-phospholipase C (PLC)
is the enzyme catalyzing hydrolysis of SM to release phospho-
choline and ceramide. After homology searches using known
sequences of bacterial SMases, two types of mammalian
SMases with pH optima in a neutral pH range were identi-
¢ed: one was named nSMase1 [13] and the other nSMase2
[14]. Subsequently, it has been revealed that nSMase1 exhibits
PLC activity toward lysophosphatidylcholine (lysoPtdCho)
and lyso platelet-activating factor (lysoPAF) [15]. nSMase2
also shows lysoPAF-PLC activity under detergent-free condi-
tions in vitro, although at a level far below the optimal level
of SMase activity of nSMase2 [16]. Moreover, it has been
shown that a plasmodial SMase is capable of hydrolyzing
lysoPtdCho and lysoPAF, and that the lysoPtdCho-PLC ac-
tivity is competed by SPC, suggesting that the plasmodial
SMase recognizes SPC as well [17]. Nevertheless, it has not
been determined whether these SMases are capable of hydro-
lyzing SPC. This is presumably because of the absence of
assay systems for SPC-PLC.
In the present study, we establish an in vitro assay system
for SPC-PLC, and demonstrate that various types of neutral
SMases catalyze e⁄cient hydrolysis of SPC in vitro. We also
discuss the substrate speci¢city of neutral SMases capable of
hydrolyzing SM and lysocholinephospholipids, but not
PtdCho or PAF.
2. Materials and methods
2.1. Materials
[Choline-methyl-14C]SM (55 mCi/mmol) and [choline-methyl-
14C]PtdCho L-K-dipalmitoyl (55 mCi/mmol) were purchased from
American Radiolabeled Chemicals Inc. [Methyl-14C]choline (55 mCi/
mmol), [methyl-14C]phosphocholine (55 mCi/mmol), 1-O-
[3H]octadecyl PAF (163 Ci/mmol), and 1-O-[3H]octadecyl lysoPAF
(163 Ci/mmol) were from Amersham Biosciences, and [palmitoyl-1-
14C]lysoPtdCho L-1-monopalmitoyl (55 mCi/mmol) was from NEN
Life Science Products. When used for PLC assays, [3H]PAF and
[3H]lysoPAF were diluted 100-fold with non-radioactive PAF and
lysoPAF (Sigma), respectively.
2.2. Preparation of enzyme sources
Human embryonic kidney (HEK) 293 cells were cultured in Dul-
becco’s modi¢ed Eagle’s medium supplemented with 10% fetal bovine
serum, 100 units/ml of penicillin, and 100 Wg/ml of streptomycin at
37‡C in a humidi¢ed 5% CO2 incubator. pHisNSM, in which human
nSMase1 cDNA was cloned on pcDNA3.1/HisC [15], was generously
provided by Dr. Yusuf A. Hannun (Department of Biochemistry and
Molecular Biology, Medical University of South Carolina, SC, USA).
The human nSMase2 cDNA sequence (GenBank accession number
XM007890) was ampli¢ed by polymerase chain reactions using a hu-
man cDNA library as template, and inserted into BamHI/NotI cloning
sites of the mammalian expression vector pcDNA3.1(+) (Invitrogen).
The resultant plasmid was named phNSM2. HEK293 cells were tran-
siently transfected with pHisNSM, phNSM2, or pcDNA3.1(+) using
FuGENE6 reagent (Roche Applied Science). Brie£y, on day 1,
1.5U106 HEK293 cells were seeded in a 100-mm dish containing 10
ml of culture medium, and cultured overnight. On day 2, the cells
were incubated with an appropriate plasmid (4 Wg) complexed with
12 Wl of FuGENE6 reagent in 8 ml of culture medium overnight. On
day 3, the transfected cells were reseeded in a 150-mm dish containing
25 ml of culture medium, and cultured overnight. Then, microsomes
were prepared from the cells as described previously [18]. In brief,
after washing with phosphate-bu¡ered saline (PBS), the transfected
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cells were collected in PBS by scraping, and centrifuged (150Ug,
5 min). The precipitated cells were suspended in 3 ml of HSEI bu¡er
(10 mM HEPES^NaOH, pH 7.5, containing 0.25 M sucrose, 1 mM
ethylenediamine tetraacetic acid (EDTA) and a protease inhibitor
cocktail), and sonicated three times with a probe-type sonicator at
20 W for 10 s. After centrifugation (1400Ug, 15 min) of the lysate,
the supernatant £uid was subjected to high-speed centrifugation
(100 000Ug, 1 h). The particulate as the microsome fraction was sus-
pended in 600 Wl of HSEI bu¡er at a protein concentration of 3^4 mg/
ml. For assays of PLC activity, the microsome fraction was diluted at
50 Wg/ml with HSEI bu¡er. As an enzyme source for plasmodial
SMase, membranes of Escherichia coli cells expressing the plasmodial
SMase as a recombinant fusion protein with glutathione transferase
were prepared as described previously [17]. Recombinant Bacillus ce-
reus SMase (Higeta Shoyu Co., Tokyo, Japan) was dissolved in 10
mM HEPES^NaOH (pH 7.5) containing 0.25 M sucrose at 1 Wg/ml.
The prepared samples were stored at 380‡C. Protein concentrations
of the preparations were determined with the Pierce bicinchoninic acid
protein assay kit with bovine serum albumin as the standard.
2.3. Preparation of [choline-methyl-14C]SPC
[Choline-methyl-14C]SM was deacylated as described previously [19]
with several modi¢cations. On 20 Wl of 50 mM sodium acetate bu¡er
(pH 5.5) containing 40 nmol of [choline-methyl-14C]SM (55 mCi/
mmol), 0.2% sodium cholate (Sigma) and 12 milliunits of sphingolipid
ceramide N-deacylase (Takara Bio Inc., Shiga, Japan), 200 Wl of do-
decane was layered, and the solution was incubated for 17 h at 37‡C.
The aqueous phase was evaporated under vacuum, dissolved in chlo-
roform/methanol (2/1, by volume), and subjected to thin-layer chro-
matography (TLC) (silica gel 60 TLC plate, Merck) with chloroform/
methanol/10% acetic acid (5/4/1, by volume) as the developing solvent.
After detection of radioactive lipids separated on the TLC plate with
a BAS2000 image analyzer (Fuji, Tokyo, Japan), the gel containing
radioactive SPC was collected in a glass tube from the plate by scrap-
ing. Then, radioactive SPC was extracted from the gel with chloro-
form/methanol/deionized water (5/4/1, by volume). After centrifuga-
tion (1400Ug, 3 min) to precipitate the gel, the supernatant fraction
containing puri¢ed radioactive SPC was evaporated under vacuum.
The dried sample was dissolved in methanol, and stored at 320‡C
until use. The radioisotopic speci¢c activity of puri¢ed [choline-meth-
yl-14C]SPC was assumed to be identical to that of the precursor [cho-
line-methyl-14C]SM. If necessary, non-radioactive standard SPC sep-
arated on a TLC plate was visualized by brilliant blue staining [20].
When used for the SPC-PLC assay, the puri¢ed radioactive SPC was
diluted two-fold with non-radioactive SPC (Matreya Inc., Pleasant
Gap, PA, USA). On the day of assays, appropriate volume of meth-
anolic solution of [choline-methyl-14C]SPC (23 mCi/mmol) was put in
a polypropylene tube, and dried by rotary evaporation. Then, dried
[14C]SPC was dissolved in deionized water at 20^50 WM by vortex
mixing and bath-type sonication (V5 min at room temperature).
Note that SPC is water-soluble.
2.4. Assays of PLC activity with various phospholipids
PLC reactions were started by adding enzyme sources to appropri-
ate assay bu¡ers. For SPC-PLC assays, microsomes (0.5 Wg protein)
were incubated in 50 Wl of 50 mM HEPES^NaOH bu¡er (pH 7.5)
containing 10 mM MgCl2, and 10 WM [choline-methyl-14C]SPC (23
mCi/mmol) in 1.5-ml polypropylene tubes at 37‡C for 30 min. The
reaction was stopped by addition of 0.8 ml of chloroform/methanol
(2/1, by volume) to the tube. After addition of 250 Wl of deionized
water, the sample was mixed vigorously, and centrifuged (10 000Ug,
2 min). 400 Wl of the aqueous upper phase was transferred to a new
tube, and evaporated under vacuum (with heating up to 60‡C, if
necessary). The dried sample was dissolved in methanol, and subjected
to TLC with methanol/0.5% NaCl/28% ammonia (50/50/1, by volume)
as the developing solvent. The radioactivity of [14C]phosphocholine
produced was analyzed with the BAS2000 image analyzer, followed
by radioactive measurements of the product with a liquid scintillation
counter. In the experiments shown in Fig. 1B (lanes 5 and 6), standard
[14C]phosphocholine and [14C]choline, respectively, were diluted with
400 Wl of the aqueous upper phase from mock incubations without the
enzyme source or substrate, dried, and applied to TLC as standards.
PLC activity toward other substrates was assayed as described pre-
viously [17,21] with minor modi¢cations. Brie£y, for assays under
detergent-replete conditions, microsomes (0.5 Wg protein) were incu-
bated in 50 Wl of 50 mM HEPES^NaOH bu¡er (pH 7.5) containing
10 mM MgCl2, 0.2 mM porcine brain phosphatidylserine (PtdSer)
(Avanti Polar Lipid Inc., Alabaster, AL, USA), 0.1% Triton X-100,
0.2% L-octylglucoside, and 10 WM radioactive substrate at 37‡C for 30
min. For assays under detergent-free conditions, Triton X-100, L-oc-
tylglucoside, and PtdSer were omitted from the assay mixture. In
some experiments, PfNSM-expressing or mock-transfected E. coli
membranes (5 Wg protein per assay), and recombinant B. cereus
SMase (10 ng protein per assay) were used as enzyme sources. In
all PLC assays, background activity from the enzyme-free controls,
in which a vehicle bu¡er instead of the enzyme source was added, was
subtracted from the activities of samples containing enzyme sources.
3. Results
3.1. SPC-PLC activity of nSMase1 and nSMase2
To obtain the substrate for SPC-PLC assays, we prepared
[choline-methyl-14C]SPC by deacylation of [choline-methyl-
14C]SM with a bacterial sphingolipid ceramide N-deacylase
(Fig. 1A). Puri¢ed [14C]SPC displayed one predominant ra-
dioactive spot on TLC (Fig. 1A). The doublet appearance of
puri¢ed [14C]SPC on TLC is possibly due to heterogeneity in
the structure of natural sphingolipid bases, in which sphingo-
sine is a major and dihydrosphingosine a minor component.
Fig. 1. SPC-PLC activity of nSMase1 and nSMase2. A: Preparation
of [choline-methyl-14C]SPC. Lane 1, commercially purchased [cho-
line-methyl-14C]SM; lane 2, [choline-methyl-14C]SM treated with
sphingolipid ceramide N-deacylase; lane 3, puri¢ed [choline-methyl-
14C]SPC. Radioactive lipids of each sample were analyzed by TLC
with a solvent of chloroform/methanol/10% acetic acid (5/4/1, by
volume). B: Hydrolysis of [14C]SPC by nSMase1 and nSMase2.
[Choline-methyl-14C]SPC was incubated in 50 mM HEPES^NaOH
bu¡er (pH 7.5) containing 10 mM MgCl2 with 0.5 Wg of mock
(lane 2), nSMase1 (lane 3) or nSMase2 microsomes (lane 4) or with-
out microsomes (lane 1) for 30 min. Then, water-soluble radioactive
compounds were analyzed by TLC with a solvent of methanol/0.5%
NaCl/28% ammonia (50/50/1, by volume). Lanes 5 and 6, standard
[14C]phosphocholine and [14C]choline, respectively. C: Time course
of SPC hydrolysis. [14C]SPC was incubated with 0.5 Wg of nSMase1
(closed circles), nSMase2 (open circles), and mock microsomes
(closed squares) for the indicated periods of time. D: Enzyme dose
dependence of SPC hydrolysis. [14C]SPC was incubated with various
doses of nSMase1 (closed circles), nSMase2 (open circles), and
mock microsomes (closed squares) for 30 min.
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For enzyme sources, we transfected HEK293 cells with a
mammalian expression vector encoding human nSMase1 or
nSMase2, and isolated microsomes (referred to as nSMase1
or nSMase2 microsomes, respectively). Microsomal prepara-
tions from empty vector-transfected cells, referred to as mock
microsomes, were used as a control. [14C]SPC was incubated
with microsomes under detergent-free conditions, and the
release of the radioactive head group from [14C]SPC was
analyzed by TLC. Both nSMase1 and nSMase2 microsomes,
but not mock microsomes, hydrolyzed SPC to release [14C]-
phosphocholine (Fig. 1B). Hydrolysis of SPC by nSMase1
and nSMase2 microsomes was almost linear for up to 30
min (Fig. 1C), and proportional to the dose of enzyme sources
up to 1.5 Wg of protein (Fig. 1D). The SPC-PLC activity of
nSMase1 and nSMase2 was severely inhibited by 0.1% Triton
X-100, regardless of the presence of 0.2 mM PtdSer in the
assay mixture (data not shown, see also Table 1). TLC anal-
ysis of chloroform-soluble lipids of the incubated samples
showed that no radioactive SM was produced during the as-
say (data not shown), ruling out the possibility that [14C]SPC
was N-acylated to form [14C]SM, from which [14C]phospho-
choline could be released by the SM-PLC reaction, during the
incubation with microsomes.
3.2. The levels of PLC activity toward various
cholinephospholipids
We also determined the PLC activity directed toward SM,
PtdCho, PAF, lysoPtdCho, and lysoPAF in the presence or
absence of 0.1% Triton X-100 and 0.2 mM exogenous PtdSer
(Table 1). For both nSMase1 and nSMase2, the level of ac-
tivity toward SM was much higher in the presence than in the
absence of detergent (Table 1). With detergent in the solution,
the levels of PLC activity toward lysoPtdCho, lysoPAF, and
SPC were less than 4% of the level of SM-PLC activity. In
contrast, under detergent-free conditions, the levels of PLC
activity of nSMase1 toward these lysocholinephospholipids
were comparable to or higher than the optimal level of SM-
PLC activity determined when detergent was present. For
nSMase2, the levels of lysoPtdCho- and lysoPAF-PLC activ-
ity determined under detergent-free conditions were still less
than 10% of the optimal level of SM-PLC activity. Neverthe-
less, the level of SPC-PLC activity of nSMase2 reached
V16% of the optimal level of SM-PLC activity (Table 1).
Exogenous PtdSer (0.2 mM) did not enhance but rather
slightly repressed the lysoPtdCho-PLC activity of both
nSMase1 and nSMase2 under detergent-free conditions (data
not shown), while PtdSer enhanced the SM-PLC activity in
the presence of detergents (data not shown; see also [14,16]).
In mock microsomes, PLC activity was negligible (Table 1).
The observed patterns of SM-, lysoPtdCho-, and lysoPAF-
PLC activities of nSMase1 and nSMase2 were consistent
with previous studies [13^16].
To examine a⁄nity for lyso substrates, PLC activity was
determined at various concentrations of SPC and lysoPtdCho.
For nSMase1, the half-optimal concentrations of SPC and
lysoPtdCho were estimated to be V0.1 and V3 WM, respec-
tively, while those to SPC and lysoPtdCho for nSMase2 were
estimated to be V5 and V3 WM, respectively (Fig. 2). These
results showed that nSMase1, but not nSMase2, has much
higher a⁄nity for SPC than for lysoPtdCho in vitro.
3.3. SPC-PLC activity of a bacterial neutral SMase
Previous studies have shown that bacterial neutral SMases
from Staphylococcus aureus and B. cereus are capable of hy-
drolyzing lysoPtdCho, but not PtdCho e⁄ciently [22,23].
However, as far as we know, it has not been determined
whether bacterial SMase also recognizes SPC-PLC. Because
bacterial SMases do not require detergents for e⁄cient hydro-
lysis of SM unlike mammalian SMases [22,23], we assayed
SM-PLC and SPC-PLC activities of puri¢ed recombinant
B. cereus SMase under detergent-free conditions. The level
of SPC-PLC activity (29.2 T 2.2 Wmol/mg protein/h, n=3)
was comparable to the level of SM-PLC (27.3 T 2.0 Wmol/mg
protein/h, n=3).
3.4. SPC-PLC activity of a plasmodial SMase
We recently identi¢ed a Plasmodium falciparum gene,
PfNSM, encoding a neutral SMase having structural similar-
ity to mammalian nSMase1 and nSMase2 [17]. Under deter-
gent-free conditions, the PfNSM product hydrolyzes lysoPtd-
Cho and lysoPAF, but not PtdCho or PAF [17]. We here
Table 1
PLC activity of nSMase1 and nSMase2 toward various substrates under detergent-replete and detergent-free conditions
Microsomes Detergenta PLC activity (nmol/mg protein/h)
SM SPC PtdCho LysoPtdCho PAF LysoPAF
nSMase1 + 367T 25 13.9T 1.1 6 0.5 6 0.5 6 0.5 4.9 T 0.8
nSMase1 3 3.4 T 2.1 434T 31 6.5 T 1.8 611T9 6 0.5 349T 31
nSMase2 + 953T 25 5.9T 2.1 6 0.5 6 0.5 6 0.5 6 0.5
nSMase2 3 15.5T 3.9 152T 14 1.1 T 1.0 92.2T 1.3 6 0.5 8.6 T 0.5
Mock + 6 0.5 6 0.5 6 0.5 6 0.5 6 0.5 6 0.5
Mock 3 6 0.5 6 0.5 6 0.5 0.6T 0.1 1.3 T 0.2 1.7 T 0.5
aAssay bu¡ers contain (+) or do not contain (3) 0.1% Triton X-100 and 0.2 mM PtdSer.
Fig. 2. Hydrolysis of SPC and lysoPtdCho at various concentrations
by nSMase1 and nSMase2. Hydrolysis of SPC (A) and lysoPtdCho
(B) by nSMase1 (closed circles) and nSMase2 (open circles) were as-
sayed at various substrate concentrations under detergent-free condi-
tions. At each substrate concentration, activity from mock-trans-
fected microsomes was also determined as a background activity,
and subtracted from the activities of nSMase1 and nSMase2 micro-
somes.
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examined its SPC-PLC activity. The membrane fraction of
bacteria expressing the PfNSM product exhibited signi¢cant
SPC-PLC activity (1.8 T 0.7 nmol/mg protein/h; n=3) under
detergent-free conditions, while SPC-PLC activity of the con-
trol membrane from mock-transfected bacteria was below the
detectable level (6 0.2 nmol/mg protein/h). For the PfNSM-
expressing membrane, SM-PLC activity (assayed under deter-
gent-replete conditions) and lysoPtdCho-PLC activity (as-
sayed under detergent-free conditions) were V14 nmol/mg
protein/h andV5 nmol/mg protein/h, respectively, being con-
sistent with our previous study [17].
4. Discussion
In the present study, we established a reliable in vitro assay
for SPC-PLC with [choline-methyl-14C]SPC as the substrate.
This system should also be applicable to the assay of SPC-
phospholipase D. Using this assay system, we demonstrated
that nSMase1 and nSMase2 are capable of hydrolyzing SPC
to release phosphocholine under detergent-free conditions
(Fig. 1 and Table 1). The SPC-PLC activity is inhibited by
the detergent Triton X-100, whereas detergent is required for
the optimal SM-PLC activity (Table 1). The levels of SPC-
PLC activity of nSMase1 and nSMase2 reached V120 and
V16%, respectively, of the optimal levels of SM-PLC activity
of these enzymes (Table 1), indicating that, like SM, SPC is an
e¡ective substrate for these enzymes, at least, in vitro.
Whereas nSMase1 recognizes SM but not PtdCho or PAF,
it e⁄ciently recognizes not only SPC (‘lysoSM’) but also ly-
soPtdCho and lysoPAF (Table 1). Similar substrate speci¢city
was observed for nSMase2, although the hydrolysis of ly-
soPtdCho and lysoPAF by nSMase2 is poor (Table 1). More-
over, B. cereus and plasmodial SMases also have similar sub-
strate speci¢city (this study and [17,22,23]). As depicted in
Fig. 3, both amido and amino groups at the C-2 position of
SM and SPC, respectively, can serve as hydrogen-bond do-
nors. By contrast, in glycerophospholipids, the ester group at
the sn-2 position of diradyl forms can not serve as a hydro-
gen-bond donor, while the hydroxyl group at this position of
lyso forms can. These results suggest that a hydrogen-bond
donor at this position is required for substrate recognition by
the PLCs for SM/lysocholinephospholipids.
The PLC activity toward lysocholinephospholipids (i.e.
SPC, lysoPtdCho, and lysoPAF), but not SM, of neutral
SMases is severely inhibited by Triton X-100 even at low
concentrations (this study and [15^17]). This di¡erential e¡ect
of the detergent might be accounted by the aspect of hydro-
phobic interaction between the enzyme and its lipid sub-
strates. SM has two hydrophobic long chains, while lysocho-
linephospholipids have one. Hence, hydrophobic interaction
of SM with the catalytic site of the enzyme could be strong
enough to form a reaction complex even in the presence of
detergents a¡ecting hydrophobic interaction, while a⁄nity of
the enzyme with lysocholinephospholipids might not be strong
enough.
Liliom et al. recently reported that SPC is present in rabbit
normal plasma and serum at V50 and V130 nM, respec-
tively [1]. They also showed that, in perfused heart prepara-
tions from guinea pigs, supplied SPC was rapidly removed
from the circulation by an unknown mechanism [1]. SPC is
accumulated in tissues of patients with Niemann^Pick disease
type A, an inherited disorder characterized by a defect in ly-
sosomal acid SMase [4]. SPC is also signi¢cantly accumulated
in the skin of atopic dermatitis patients, compared to healthy
controls [7], and this accumulation has been suggested to be
due to the induction of endogenous or (infected bacteria-de-
rived) exogenous SM deacylase [24]. Abnormally accumulated
SPC may be involved in the pathogenicity of these diseases.
Thus, the regulation of SPC levels in low concentration ranges
could be an important physiological function. nSMase1 is
widely expressed in various tissues [13], while nSMase2 is
predominantly expressed in the brain [14]. Interestingly,
nSMase1 acts as a high-a⁄nity SPC-PLC under detergent-
free conditions (Fig. 2). Collectively, we propose the previ-
ously unrecognized possibility that the SPC-PLC activity of
nSMase1 and/or nSMase2 contributes to the regulation of
Fig. 3. Structures of choline-containing phospholipids. The groups
highlighted by gray ovals are capable of acting as hydrogen-bond
donors at the C-2 position of the sphingolipids or at the sn-2 posi-
tion of the glycerolipids.
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SPC levels in vivo, although more studies are needed to test
this hypothesis.
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